View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Gastrointestinal Cancer News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 10, 2023
3 min read
Save

Elevated BMI in adulthood may increase GI cancer risk, regardless of aspirin use

Elevated BMI in adulthood may increase GI cancer risk, regardless of aspirin use

Overweight and obese BMI during adulthood appeared associated with increased risk for colorectal cancer and noncolorectal gastrointestinal cancers, according to study results published in JAMA Network Open.

SPONSORED CONTENT
May 10, 2023
2 min watch
Save

VIDEO: Neoadjuvant, adjuvant studies show promise in preventing HCC recurrence

VIDEO: Neoadjuvant, adjuvant studies show promise in preventing HCC recurrence

In this video, Thomas Marron, MD, PhD, discussed the larger implications of hepatocellular carcinoma treatments presented at American Association for Cancer Research Annual Meeting.

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
May 10, 2023
2 min read
Save

Gut microbiome may influence pancreatic cancer survival

Gut microbiome may influence pancreatic cancer survival

Stool from long-term survivors of pancreatic adenocarcinoma had an increased relative abundance of the bacterial species Faecalibacterium prausnitzii and Akkermansia mucinophilia, according to data published in Cancer.

SPONSORED CONTENT
May 09, 2023
4 min watch
Save

VIDEO: Circulating tumor DNA levels could help predict hepatocellular carcinoma recurrence

VIDEO: Circulating tumor DNA levels could help predict hepatocellular carcinoma recurrence

In this video, Thomas Marron, MD, PhD, discussed data he presented on patients with liver cancer treated with neoadjuvant cemiplimab (Libtayo, Regeneron) at American Association for Cancer Research Annual Meeting.

SPONSORED CONTENT
May 09, 2023
4 min watch
Save

VIDEO: Following up IMbrave050 study will be important in hepatocellular carcinoma

VIDEO: Following up IMbrave050 study will be important in hepatocellular carcinoma

In this video, Thomas Marron, MD, PhD, discussed results from the phase 3 IMbrave050 study, presented at American Association for Cancer Research Annual Meeting.

SPONSORED CONTENT
May 08, 2023
2 min read
Save

Telemedicine garners higher rankings than in-person visits among patients with cancer

Telemedicine garners higher rankings than in-person visits among patients with cancer

Telemedicine garnered higher satisfaction ratings than in-person visits among patients with cancer in terms of access and care provider concern, according to a study published in Journal of the National Comprehensive Cancer Network.

SPONSORED CONTENT
May 08, 2023
2 min read
Save

Aspirin, NSAIDs use may reduce risk for early-onset CRC, further study warranted

Aspirin, NSAIDs use may reduce risk for early-onset CRC, further study warranted

CHICAGO — The regular use of aspirin and NSAIDs was associated with a lower risk for early-onset adenomas, especially those with advanced histology, according to a researcher at Digestive Disease Week.

SPONSORED CONTENT
May 08, 2023
3 min watch
Save

VIDEO: KEYNOTE-966 study bodes well for future bile tract cancer studies

VIDEO: KEYNOTE-966 study bodes well for future bile tract cancer studies

In this video, Ahmed Kaseb, MD, CMQ, discussed results from the phase 3 KEYNOTE-966 study, presented at American Association for Cancer Research Annual Meeting.

SPONSORED CONTENT
May 08, 2023
4 min watch
Save

VIDEO: IMbrave050 trial shows ‘exciting’ results in hepatocellular carcinoma

VIDEO: IMbrave050 trial shows ‘exciting’ results in hepatocellular carcinoma

In this video, Ahmed Kaseb, MD, CMQ, discussed results from the phase 3 IMbrave050 trial, presented at American Association for Cancer Research Annual Meeting.

SPONSORED CONTENT
May 07, 2023
1 min read
Save

Dedicated patient navigator cost-effective, improved FIT return rates by nearly 38%

Dedicated patient navigator cost-effective, improved FIT return rates by nearly 38%

CHICAGO — Adding a dedicated patient navigator improved fecal immunochemical testing completion and return rates and resulted in significant savings to the health care system, according to data presented at Digestive Disease Week.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails